X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (39) 39
metallurgy (39) 39
organic chemistry (39) 39
peptides (39) 39
human necessities (26) 26
hygiene (26) 26
medical or veterinary science (26) 26
specific therapeutic activity of chemical compounds ormedicinal preparations (26) 26
preparations for medical, dental, or toilet purposes (4) 4
adult (3) 3
humans (3) 3
index medicus (3) 3
precursor b-cell lymphoblastic leukemia-lymphoma - therapy (3) 3
trials (3) 3
abridged index medicus (2) 2
adult patients (2) 2
antibodies, bispecific - adverse effects (2) 2
antibodies, bispecific - pharmacokinetics (2) 2
antibodies, bispecific - therapeutic use (2) 2
antigens, cd19 - immunology (2) 2
cd3 complex - immunology (2) 2
clinical-significance (2) 2
combined modality therapy (2) 2
disease-free survival (2) 2
hematology (2) 2
immunotherapy - methods (2) 2
kaplan-meier estimate (2) 2
minimal residual disease (2) 2
neoplasm, residual (2) 2
prognostic-factors (2) 2
quantification (2) 2
standard-risk (2) 2
therapy (2) 2
activation (1) 1
acute lymphoblastic-leukemia (1) 1
agammaglobulinemia - chemically induced (1) 1
aged (1) 1
aged, 80 and over (1) 1
antibodies, bispecific - administration & dosage (1) 1
antibody specificity (1) 1
antigens, neoplasm - immunology (1) 1
antilymphocyte serum - administration & dosage (1) 1
antilymphocyte serum - adverse effects (1) 1
antilymphocyte serum - metabolism (1) 1
antineoplastic agents - therapeutic use (1) 1
b-lymphocytes - immunology (1) 1
b-lymphocytes - pathology (1) 1
bone marrow - pathology (1) 1
cancer (1) 1
cell lineage (1) 1
cell-engaging antibody (1) 1
construct (1) 1
cytotoxicity (1) 1
cytotoxicity, immunologic - drug effects (1) 1
drug delivery systems (1) 1
drug resistance, neoplasm (1) 1
female (1) 1
follow-up studies (1) 1
hematopoietic stem cell transplantation (1) 1
immune system - drug effects (1) 1
immunologic factors - administration & dosage (1) 1
immunologic factors - adverse effects (1) 1
immunologic factors - pharmacokinetics (1) 1
immunotherapy - adverse effects (1) 1
infusion pumps (1) 1
lymphocyte activation (1) 1
lymphocyte activation - drug effects (1) 1
lymphopenia - chemically induced (1) 1
male (1) 1
melanoma (1) 1
middle aged (1) 1
molecular targeted therapy (1) 1
mrd (1) 1
oncology (1) 1
potent (1) 1
precursor b-cell lymphoblastic leukemia-lymphoma - blood (1) 1
precursor b-cell lymphoblastic leukemia-lymphoma - diagnosis (1) 1
precursor b-cell lymphoblastic leukemia-lymphoma - drug therapy (1) 1
precursor b-cell lymphoblastic leukemia-lymphoma - immunology (1) 1
precursor b-cell lymphoblastic leukemia-lymphoma - metabolism (1) 1
precursor b-cell lymphoblastic leukemia-lymphoma - mortality (1) 1
precursor b-cell lymphoblastic leukemia-lymphoma - pathology (1) 1
recurrence (1) 1
relapse (1) 1
remission induction (1) 1
single-chain antibody (1) 1
survival analysis (1) 1
t-cell antigen receptor specificity - drug effects (1) 1
t-cell antigen receptor specificity - immunology (1) 1
t-lymphocytes - drug effects (1) 1
t-lymphocytes - immunology (1) 1
t-lymphocytes, cytotoxic - drug effects (1) 1
t-lymphocytes, cytotoxic - immunology (1) 1
transplantation (1) 1
transplantation, homologous (1) 1
treatment outcome (1) 1
vaccines (1) 1
young adult (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (43) 43
French (7) 7
German (5) 5
Chinese (4) 4
Croatian (2) 2
Danish (2) 2
Portuguese (2) 2
Serbian (2) 2
Slovenian (2) 2
Spanish (2) 2
Greek (1) 1
Hungarian (1) 1
Japanese (1) 1
Korean (1) 1
Lithuanian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 18, pp. 2493 - 2498
Journal Article
Blood, ISSN 0006-4971, 12/2012, Volume 120, Issue 26, pp. 5185 - 5187
Journal Article
Blood, ISSN 0006-4971, 06/2012, Volume 119, Issue 26, pp. 6226 - 6233
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 4460 - 4460
Abstract Introduction: Treatment of relapsed or refractory DLBCL can be challenging and little progress has been made in recent years. Blinatumomab, a... 
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 1811 - 1811
Abstract Introduction Blinatumomab, a bispecific T-cell engager (BiTE®) that redirects cytotoxic T cells to CD19+ B-lineage cells, has shown anticancer... 
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 1637 - 1637
Abstract Abstract 1637 Blinatumomab (MT103) is a single-chain bispecific antibody construct with specificity for CD19 and CD3 belonging to the class of... 
Journal Article
Blood, ISSN 0006-4971, 11/2010, Volume 116, Issue 21, pp. 174 - 174
Abstract Abstract 174 Blinatumomab, a bispecific, T cell-engaging (BiTE®) antibody, can effectively redirect T cells for highly selective lysis of CD19+ target... 
Journal Article
10/2019
The present invention relates to a method for the treatment, amelioration or elimination of acute lymphoblastic leukemia (ALL), the method comprising the... 
METALLURGY | PEPTIDES | ORGANIC CHEMISTRY | CHEMISTRY
Patent
08/2019
The present invention relates to a method for the treatment, amelioration or elimination of acute lymphoblastic leukemia (ALL), the method comprising the... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | METALLURGY | PEPTIDES | HYGIENE | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
07/2019
The present invention relates to a method for the treatment, amelioration or elimination of acute lymphoblastic leukemia (ALL), the method comprising the... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | METALLURGY | PEPTIDES | HYGIENE | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
07/2019
The present invention relates to a method for the treatment, amelioration or elimination of acute lymphoblastic leukemia (ALL), the method comprising the... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | METALLURGY | PEPTIDES | HYGIENE | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
06/2019
The present invention relates to a method for the treatment, amelioration or elimination of acute lymphoblastic leukemia (ALL), the method comprising the... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | METALLURGY | PEPTIDES | HYGIENE | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
06/2019
The present invention relates to a method for the treatment, amelioration or elimination of acute lymphoblastic leukemia (ALL), the method comprising the... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | METALLURGY | PEPTIDES | HYGIENE | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
05/2019
The present invention relates to a method for the treatment, amelioration or elimination of acute lymphoblastic leukemia (ALL), the method comprising the... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | METALLURGY | PEPTIDES | HYGIENE | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
Blood, ISSN 0006-4971, 11/2009, Volume 114, Issue 22, pp. 840 - 840
Abstract Abstract 840 Introduction: In patients with B-precursor ALL, presence of MRD after induction therapy or at any time point later predicts a... 
Journal Article
03/2019
The present invention relates to a method for the treatment, amelioration or elimination of acute lymphoblastic leukemia (ALL), the method comprising the... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | METALLURGY | PEPTIDES | HYGIENE | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
11/2018
The present invention relates to a method for the treatment, amelioration or elimination of acute lymphoblastic leukemia (ALL), the method comprising the... 
METALLURGY | PEPTIDES | ORGANIC CHEMISTRY | CHEMISTRY
Patent
08/2018
The present invention relates to a method for the treatment, amelioration or elimination of acute lymphoblastic leukemia (ALL), the method comprising the... 
METALLURGY | PEPTIDES | ORGANIC CHEMISTRY | CHEMISTRY
Patent
09/2017
The present invention relates to a method for the treatment, amelioration or elimination of acute lymphoblastic leukemia (ALL), the method comprising the... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | METALLURGY | PEPTIDES | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
09/2017
The present invention relates to a method for the treatment, amelioration or elimination of acute lymphoblastic leukemia (ALL), the method comprising the... 
METALLURGY | PEPTIDES | ORGANIC CHEMISTRY | CHEMISTRY
Patent
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.